Click here for the COVID-19 emerging and re-emerging waves Virtual conference 2021 Background COVID-19 came…
New and original papers are now welcome to Special Journal of Public health: We are looking for Manuscripts that clearly elucidate any one or more that one of the following points for publication in our forthcoming issue scheduled for March 2020. Submit your papers here!!!!!!!!!!!!!
Solicited papers can hardly be rejected since the editorial office works with authors to get the best out of such papers before they are sent out for peer review and publication. Unless the authors are not willing to work closely with the editorial office to achieve such goal before we advise authors to withdraw such papers. However, working with the editorial office is not a guarantee such paper will be accepted since the issue of acceptance include feedback from 2 or more independent external reviewers
New manuscript area of interest
- New bacteria, viruses, fungi and parasites emerge and evolve each year globally with no clear documentation algorithms in developing countries.
- Densely populated regions and easy travel accelerate the spread of infectious disease in many countries with no surveillance to keep track with disease epidemic
- Antimicrobial resistance remains a key worldwide health fear. Millions develop drug-resistant infections each year and resistance need proper documentation for effective management and intervention at the grass root
- Human papillomavirus is linked to cervical cancer and the strength of this linkage is still not very well understood especially in developing countries. There are other Microorganisms that can serve as predictors of more complex disease which we cannot afford to manage due to poor resources. We know a little about this predictors and yet knowing them could save lots of lives and money which we do not even have
- Helicobacter pylori is linked to stomach cancer and peptic ulcers and the strength of this linkage and the distribution is not well known.
- Hepatitis B and C are linked to liver cancer and the population at risk and distribution is not well understood. Disease predictors announce the emergence of disease long before the disease becomes overt enabling planners to stage a good fight against such diseases
- Diagnosis can improve the effectiveness of treatments and avoid long-term complications for the infected patient but access, cost, and acceptance of this diagnostic protocols is still a mirage in many developing country settings
- Undiagnosed patients can mistakenly spread the disease to others. Early diagnosis can help to prevent or stop an outbreak but many factors militating against the effective usage of diagnosis to mount effective intervention continue to skyrocket making disease transmission a sustained nightmare to service providers
- Extensive abuse and waste of antibiotics lead to antibiotic resistance. Diagnostic tests can determine when antibiotics are suitable treatment—and when they are not. However, the role of re-infection and changing disease epidemiology seems to have negated the gains of effective intervention making disease failure a myth
- Infectious diseases remain associated with a high economic burden in many countries but undefined underlying factors continue to mar the efforts of service providers and donors making disease control look like a wild goose chase
- Use of a diagnostic test for the early detection of MRSA allowed doctors to recommend best antibiotics days sooner, decreasing the extent of hospital stays by 6.2 days and lowering hospital costs but remote hard to reach areas where there is no doctor to ask for and interpret diagnostic test makes polypharmacy the sustained origin and promoter of microbial resistance
- Point of care testing allows patient diagnoses where care is provided outside the main laboratories. The results allow for fast treatment. However lost to follow up, and the reluctance of stakeholders to confirm tests for effective intervention especially after they seem to be recuperating including cost still makes POC debatable in many quarters
- Test manufacturers developed new rapid diagnostic tests to avoid multi-day delays in diagnosing Ebola affected patients. Unfortunately, the population in need still surpasses the available services including many unreported cases dying in silence but needs attention